Qualigen Therapeutics Stock Surges 75% Pre-Market on BitGo Digital Treasury Deal
Qualigen Therapeutics (QLGN) shares skyrocketed 75% in pre-market trading following the announcement of a $30 million digital treasury partnership with BitGo. The biotech firm's strategic pivot into digital assets marks a significant shift toward tech-driven financial management.
BitGo's institutional-grade custody infrastructure will secure Qualigen's multi-asset treasury portfolio, combining liquidity access with blockchain security. Market reaction was immediate, with trading volume spiking as investors priced in the long-term advantages of this treasury overhaul.
The move positions Qualigen among a growing cohort of public companies diversifying into digital assets. While the specific crypto allocations remain undisclosed, the partnership signals confidence in blockchain-based treasury management at institutional scale.